Literature DB >> 25006717

Drug companies' patient-assistance programs--helping patients or profits?

David H Howard1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25006717     DOI: 10.1056/NEJMp1401658

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D.

Authors:  Jinoos Yazdany; R Adams Dudley; Randi Chen; Grace A Lin; Chien-Wen Tseng
Journal:  Arthritis Rheumatol       Date:  2015-06       Impact factor: 10.995

2.  Pharmacy Benefit Management Companies: Do They Create Value in the US Healthcare System?

Authors:  Alan Lyles
Journal:  Pharmacoeconomics       Date:  2017-05       Impact factor: 4.981

3.  Reducing Out-of-Pocket Costs to Coordinate Prescription Medication Benefit Design with Chronic Disease Outreach and Clinical Care.

Authors:  Mary Reed
Journal:  J Gen Intern Med       Date:  2017-05       Impact factor: 5.128

4.  Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population.

Authors:  Aaron S Kesselheim; Jessica M Franklin; Seoyoung C Kim; John D Seeger; Daniel H Solomon
Journal:  J Gen Intern Med       Date:  2015-04-09       Impact factor: 5.128

5.  Use of Charity Financial Assistance for Novel Oral Anticancer Agents.

Authors:  Adam J Olszewski; Andrew R Zullo; Christopher R Nering; Justin P Huynh
Journal:  J Oncol Pract       Date:  2018-02-13       Impact factor: 3.840

6.  Effects of Affordable Care Act Marketplaces and Medicaid Eligibility Expansion on Access to Cancer Care.

Authors:  John A Graves; Katherine Swartz
Journal:  Cancer J       Date:  2017 May/Jun       Impact factor: 3.360

Review 7.  Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA.

Authors:  Daniel M Hartung
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

8.  The Affordable Care Act and Adolescents and Young Adults With Cancer: Much Progress, but Challenges Remain.

Authors:  Peter Hsu; John A Graves
Journal:  JAMA Oncol       Date:  2018-08-01       Impact factor: 31.777

Review 9.  Breaking the Bank: Three Financing Models for Addressing the Drug Innovation Cost Crisis.

Authors:  J D Kleinke; Nancy McGee
Journal:  Am Health Drug Benefits       Date:  2015-05

10.  Financial Eligibility Criteria and Medication Coverage for Independent Charity Patient Assistance Programs.

Authors:  So-Yeon Kang; Aditi Sen; Ge Bai; Gerard F Anderson
Journal:  JAMA       Date:  2019-08-06       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.